Related Experiment Video
Updated: Jun 28, 2025
Author Spotlight: Enhancing Skin Model Diversity with Cost-Effective 3D Cellular Models
Published on: October 20, 2023
Adaptive designs in dermatology clinical trials: Current status and future perspectives
D Potvin1, P D'Angelo1, S Bennett1
1Innovaderm Research Inc, Montreal, Quebec, Canada.
Abstract:
Current drug development strategies present many challenges that can impede drug approval by regulatory agencies. Alternative study models, such as adaptive trial designs, have recently sparked interest, as they provide a flexible and more efficient approach in conducting clinical trials. Adaptive trial designs offer several potential benefits over traditional randomized controlled trials, which include decrease in costs, reduced clinical development time and limiting exposure of patients to potentially ineffective treatments allowing completion of studies with fewer patients. This article explores the current use of adaptive trial designs in non-oncologic skin diseases and highlights the most common types of adaptive designs used in the field. We also review the operational challenges and statistical considerations associated with such designs and propose clinical development strategies to successfully implement adaptive designs. The article also proposes instances where adaptive trial designs are particularly beneficial, and other situations where they may not be very useful.
Insights
Adaptive trial designs offer a flexible and efficient approach to clinical trials, reducing costs and development time for non-oncologic skin diseases. These innovative methods can limit patient exposure to ineffective treatments, improving study completion rates.
Area of Science:
- Dermatology
- Clinical Trial Design
- Drug Development
Background:
- Traditional drug development faces regulatory hurdles and inefficiencies.
- Adaptive trial designs are emerging as a flexible alternative for clinical studies.
Purpose of the Study:
- To explore the application of adaptive trial designs in non-oncologic skin diseases.
- To review common adaptive designs, operational challenges, and statistical considerations.
- To propose strategies for successful implementation and identify optimal use cases.
Main Methods:
- Review of current adaptive trial designs in dermatologic research.
- Analysis of operational and statistical challenges.
- Identification of beneficial and non-beneficial scenarios for adaptive designs.
Main Results:
- Adaptive designs offer potential benefits like reduced costs and faster development timelines.
- Common adaptive designs and their specific applications in dermatology are highlighted.
- Operational and statistical considerations for implementation are discussed.
Conclusions:
- Adaptive trial designs present a promising, efficient approach for drug development in non-oncologic skin diseases.
- Successful implementation requires careful consideration of operational and statistical factors.
- Understanding specific use cases is crucial for maximizing the benefits of adaptive designs.
More Related Videos
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
06:30Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform
Published on: May 17, 2021
Related Concept Videos
01:11Clinical Trials: Overview
01:16Clinical Trials
There are four phases in a clinical trial. A phase one...
01:28Preclinical Development: Overview
01:28Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:26Drug Discovery: Overview